ArticleJTO clinical and research reports2025
Patient-Reported Outcomes From LIBRETTO-431: First-Line Selpercatinib Versus Chemotherapy With Pembrolizumab in
Caicun Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ArticleJTO clinical and research reports2025
Caicun Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.